Back

Answers in CME Inc. (AiCME)

  • Estrogen Replacement Therapy

Hot Updates in Menopause Management: Personalizing VMS Care With Novel Neurokinin-Targeted Therapies

This enduring dialogue aims to strengthen OB/GYNs’, family practice physicians’, and APPs’ ability to apply the evidence for NK-receptor antagonists and patient-centered strategies to optimize treatment of menopause-associated VMS. As a result of this educational activity, learners will be better able to: 1. Recognize unmet therapeutic needs among patients with menopause-associated VMS; 2. Assess the evidence for nonhormonal therapies targeting NK receptors in the treatment of menopause-associated VMS; and, 3. Formulate patient-focused strategies for the optimal use of NK-receptor antagonists for menopause-associated VMS. Learners have access to downloadable materials for future use in practice.

Credit & MOC Details

Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.

Credit types

AMA PRA Category 1 Credit™Up to 0.5 credits

MOC types

No MOC

FDA REMS

No

Qualifies for MIPS

No

Pricing

Free

Reported to ACCME by the provider

  • Microlearning
  • Credit · Up to 0.5 credits
  • Commercial Support
  • Released
    Aug 20, 2026
  • Last day to claim credit
    Aug 20, 2027 10 months left